Richard A. Miller M.D., President and CEO at Corvus Pharmaceuticals, Inc. (CRVS), bought 15,212 shares at $3.67 ($53K) on 2019-06-11, disclosed to the SEC on 2019-06-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.37 | 9,212 | $31K | 58.5% |
| 2 | $3.67 | 6,000 | $22K | 41.5% |
| Total | $3.49 avg | 15,212 | $53K | 100% |
| Filing → |
| CRVS | BUY | 2022-12-15 | $45K | — | Filing → |
| CRVS | BUY | 2022-09-28 | $19K | — | Filing → |
| CRVS | BUY | 2022-09-20 | $16K | — | Filing → |